| Dr Jeffrey L Fischer, MD | |
|
1801 19th Ave Sw, Willmar, MN 56201-4946 | |
| (320) 235-2020 | |
| (320) 214-5761 |
| Full Name | Dr Jeffrey L Fischer |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 32 Years |
| Location | 1801 19th Ave Sw, Willmar, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386693604 | NPI | - | NPPES |
| 849894600 | Medicaid | MN | |
| 180044363 | Other | MN | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 39771 (Minnesota) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Fischer Laser Eye Center Llc | 6406756295 | 6 |
News Archive
Almost three quarters of Britain's young men and women are boosting their risk of potentially fatal skin cancer in their search for a suntan. A specially commissioned survey for Cancer Research UK today reveals that 70 per cent of 16 to 24 year olds still want a tan on holiday despite warnings of over exposure to the sun.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
The U.S. Food and Drug Administration recently approved the first new drug to fight tuberculosis (TB) in more than 40 years, but treatment still takes six months, 200 pills and leaves 40 percent of patients uncured. Thus, new targets are needed. Today in ACS Central Science, researchers report they have identified one such target - a gene that allows the disease to camp out in human immune cells, and is thus essential for the organism's proliferation.
On National Kidsafe Day, parents and carers of children are being urged to consider whether they are buckling up properly before hitting the road.
› Verified 4 days ago
| Entity Name | Fischer Laser Eye Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558310623 PECOS PAC ID: 6406756295 Enrollment ID: O20040109000216 |
News Archive
Almost three quarters of Britain's young men and women are boosting their risk of potentially fatal skin cancer in their search for a suntan. A specially commissioned survey for Cancer Research UK today reveals that 70 per cent of 16 to 24 year olds still want a tan on holiday despite warnings of over exposure to the sun.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
The U.S. Food and Drug Administration recently approved the first new drug to fight tuberculosis (TB) in more than 40 years, but treatment still takes six months, 200 pills and leaves 40 percent of patients uncured. Thus, new targets are needed. Today in ACS Central Science, researchers report they have identified one such target - a gene that allows the disease to camp out in human immune cells, and is thus essential for the organism's proliferation.
On National Kidsafe Day, parents and carers of children are being urged to consider whether they are buckling up properly before hitting the road.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jeffrey L Fischer, MD 1801 19th Ave Sw, Willmar, MN 56201-4946 Ph: (320) 235-2020 | Dr Jeffrey L Fischer, MD 1801 19th Ave Sw, Willmar, MN 56201-4946 Ph: (320) 235-2020 |
News Archive
Almost three quarters of Britain's young men and women are boosting their risk of potentially fatal skin cancer in their search for a suntan. A specially commissioned survey for Cancer Research UK today reveals that 70 per cent of 16 to 24 year olds still want a tan on holiday despite warnings of over exposure to the sun.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
The U.S. Food and Drug Administration recently approved the first new drug to fight tuberculosis (TB) in more than 40 years, but treatment still takes six months, 200 pills and leaves 40 percent of patients uncured. Thus, new targets are needed. Today in ACS Central Science, researchers report they have identified one such target - a gene that allows the disease to camp out in human immune cells, and is thus essential for the organism's proliferation.
On National Kidsafe Day, parents and carers of children are being urged to consider whether they are buckling up properly before hitting the road.
› Verified 4 days ago
Dr. Gregory G. Nelson, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 101 Willmar Ave Sw, Willmar, MN 56201 Phone: 320-231-5079 | |
Dr. Ina Drown, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1604 1st St S, Willmar, MN 56201 Phone: 320-231-5039 Fax: 320-231-5067 | |
Dr. Katherine Shin, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 101 Willmar Ave Sw, Willmar, MN 56201 Phone: 320-231-5000 Fax: 320-231-5067 | |
Dr. Timothy R Pieh, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 101 Willmar Ave Sw, Willmar, MN 56201 Phone: 320-231-5000 Fax: 320-231-5067 |